v3.26.1
Equity Securities
3 Months Ended
Mar. 31, 2026
Equity Securities [Abstract]  
Equity Securities
Note 4:  Equity Securities
Equity securities include noncontrolling ownership interests in third-party entities, such as corporations, partnerships, or limited liability companies. Trading equity securities are held for customer accommodation and market-making purposes and are classified within trading assets on our consolidated balance sheet. Non-trading equity securities are held for investment purposes and are classified within equity securities on our
consolidated balance sheet. For additional information on trading equity securities, see Note 11 (Fair Value Measurements).

Non-Trading Equity Securities
Table 4.1 provides a summary of our equity securities by business purpose and accounting method.
Table 4.1: Equity Securities
(in millions)
Mar 31,
2026
Dec 31,
2025
Equity securities at fair value (1)$1,765 2,008 
Tax credit investments (2)21,102 21,395 
Private equity (3)13,304 13,206 
Federal Reserve Bank stock and other at cost (4)4,955 4,323 
Total equity securities$41,126 40,932 
(1)Includes securities subject to contractual lock-up periods restricting their sale. These securities had fair values of $295 million at March 31, 2026, the majority of which have sale restrictions that will expire in second quarter 2027, and $218 million at December 31, 2025, the majority of which have sale restrictions that will expire in second quarter 2027.
(2)Includes affordable housing investments of $11.3 billion and $11.6 billion at March 31, 2026, and December 31, 2025, respectively, and renewable energy investments of $9.6 billion at both March 31, 2026, and December 31, 2025. The renewable energy investments are presented net of deferred investment tax credits of $1.8 billion and $1.7 billion at March 31, 2026, and December 31, 2025, respectively. Tax credit investments are accounted for using either the proportional amortization method or the equity method. See Note 12 (Securitizations and Variable Interest Entities) for information about tax credit investments.
(3)Includes equity securities accounted for under the measurement alternative of $9.8 billion at both March 31, 2026, and December 31, 2025, which were predominantly securities associated with our venture capital investments. The remaining securities are accounted for using the equity method.
(4)Includes $3.5 billion of investments in Federal Reserve Bank stock at both March 31, 2026, and December 31, 2025, and $1.4 billion and $762 million of investments in Federal Home Loan Bank stock at March 31, 2026, and December 31, 2025, respectively.
Table 4.2 provides a summary of the net gains and losses from equity securities, which excludes equity method adjustments for our share of the investee’s earnings or losses that are recognized
in other noninterest income. Gains and losses from equity securities are reported in net gains from trading and securities.
Table 4.2: Net Gains (Losses) from Equity Securities
Quarter ended March 31,
(in millions)20262025
Net losses from equity securities carried at fair value
$(169)(195)
Net gains (losses) from equity securities not carried at fair value (1):
Impairment write-downs
(115)(194)
Net unrealized gains (2)
163 
Net realized gains
293 45 
Total net gains (losses) from equity securities not carried at fair value341 (148)
Total net gains (losses) from equity securities$172 (343)
(1)Includes amounts related to venture capital investments in consolidated portfolio companies, which are not reported in equity securities on our consolidated balance sheet.
(2)Includes unrealized gains (losses) due to observable price changes from equity securities accounted for under the measurement alternative.
Table 4.3 provides additional information about the net gains and losses from equity securities accounted for under the measurement alternative. Gains and losses related to these adjustments are also included in Table 4.2.
Table 4.3: Net Gains (Losses) from Measurement Alternative Equity Securities
Quarter ended March 31,
(in millions)20262025
Net gains (losses) recognized in earnings during the period:
Gross unrealized gains from observable price changes$171 43 
Gross unrealized losses from observable price changes (25)
Impairment write-downs
(65)(165)
Net realized gains from sale192 15 
Total net gains (losses) recognized during the period
$298 (132)
Table 4.4 presents cumulative carrying value adjustments to equity securities accounted for under the measurement alternative that were still held at the end of each reporting period presented.
Table 4.4: Measurement Alternative Cumulative Gains (Losses)
(in millions)
Mar 31,
2026
Dec 31,
2025
Cumulative gains (losses):
Gross unrealized gains from observable price changes$7,617 7,737 
Gross unrealized losses from observable price changes(101)(100)
Impairment write-downs(3,755)(3,861)